Skip to content
OpenCapital
Get started

Arcadia Biosciences RKDA Q1 2026 Annual earnings

Reported May 14, 2026 · Before market open

Revenue$1.1MMiss by $500.0K
EPS-$2.11Miss by $1.31
Revenue estimate$1.6M
EPS estimate-$0.80

Next report

Aug 19, 2026 (In 2 weeks)
Revenue estimate$1.9M
EPS estimate-$0.56

Versus estimates

Revenue

Q1 2026$1.1MMiss by $500.0K
Q4 2025$901.0KMiss by $499.0KQ3 2025$1.3MMiss by $598.0KQ2 2025$1.5MMiss by $745.0KQ1 2025$1.2MMiss by $100.0KQ4 2024$1.2MBeat by $66.0K

Diluted EPS

Q1 2026-$2.11Miss by $1.31
Q4 2025-$0.98Miss by $0.32Q3 2025$0.62Beat by $1.16Q2 2025$0.02Beat by $0.81Q1 2025$1.90Beat by $2.88Q4 2024-$2.48Miss by $1.59

Ask the moment Arcadia Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Arcadia Biosciences report Q1 2026 earnings?
Arcadia Biosciences (RKDA) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Arcadia Biosciences's Q1 2026 revenue and EPS?
Arcadia Biosciences reported revenue of $1.1M and eps of $-2.11 for Q1 2026.
Did Arcadia Biosciences beat estimates in Q1 2026?
Revenue missed the consensus estimate of $1.6M by $500.0K. EPS missed the consensus estimate of $-0.80 by $1.31.
How did Arcadia Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 8.3% from $1.2M a year earlier.
Where can I find Arcadia Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-223985) and the 10-K/A periodic report (0001193125-26-197315) directly on SEC EDGAR. The filing index links above go to sec.gov.